Framingham Company Awarded $47 Million Grant For Alzheimer’s Treatment
editor The following is a press release *** FRAMINGHAM – Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease (AD) and other neurodegenerative…